PPT-HIV and HCV Update for the Pharmacist – June 2014

Author : marina-yarberry | Published Date : 2016-06-30

John J Faragon PharmD BCPS AAHIVP Regional Pharmacy Director NYNJ AETC Pharmacist Albany Medical Center Objectives Discuss recent guidelines changes for HIV

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "HIV and HCV Update for the Pharmacist �..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

HIV and HCV Update for the Pharmacist – June 2014: Transcript

John J Faragon PharmD BCPS AAHIVP Regional Pharmacy Director NYNJ AETC Pharmacist Albany Medical Center Objectives Discuss recent guidelines changes for HIV infection Using patient cases discuss the role of . Todd S. Wills, MD. SPNS HCV Treatment Expansion Initiative. Evaluation and Technical Assistance Center. Infectious Disease Specialist. HCV Response Rates in HIV+ and HIV- Patients Treated With . PegIFN. HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Prevalence. . among. . People. . Who. . Inject. . Drugs. : . Results. . from. . the. . First. . Integrated. Bio-. behavioral. . Survey. . of. PWID . in. Mozambique. Authors. : . Cynthia SEMÁ-BALTAZAR. Cathryn. L. Samples, MD, MPH, AAHIVS. Director, Boston HAPPENS. Boston Children’s Hospital. Presented at: Improving . Care for Substance Use, HIV and HCV in Adolescents: . Effective Approaches to Assessing, Treating, and Engaging . Presented by: . Fabian Cretu, Beverly-Ann Oliver, Kristina Miclat, Maeryl Sumagang. PHM142. September 25, 2018. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Amber Wheeler, MD. WIHS Scientific Meeting. June 30, 2014. Objectives. To discuss:. Background . Aims. Preliminary “rough” data. Future Directions. HIV-infected . persons have increased. odds of . 30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 20. Days Since. . Infection. HIV RNA. . (plasma). HIV. . Antibody. HIV p24. . Ag. IgM. IgG. FIGURE . 1: LABORATORY . MARKERS . OF HIV. . INFECTION. Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017. Available HCV treatment DAAs. Epclusa. (. sofosbuvir. / . velpatasvir. ). Harvoni. (. sofosbuvir. / . ledipasvir. ). Zepatier. (. grazoprevir. / . Mark Sulkowski, . MD. Professor of Medicine. Medical Director, Viral Hepatitis Center . Johns Hopkins University. Baltimore Maryland USA. Liver disease is the second leading specific causes of death amongst HIV-positive individuals in the D:A:D study. Marguerite Beiser, ANP-BC, AAHIVS. Boston Health Care for the Homeless Program. Regis College . 11/14/18 . I have no disclosures. Outline. Hepatitis C (HCV). Pathophysiology. Epidemiology. Screening . Teri Griep-Langholz, RN, HIV/HCV Program Nurse Case Manager. Siouxland Community Health Center. Sioux City, IA . Beyond the Yellow Brick Road—Incorporating HCV into HIV Treatment Model. Learning Objectives. Our Services. Emotional:. Reactions. Feelings about Ourselves & Others. Spiritual:. Values. Self Esteem & Acceptance. Balance & Connection. Physical:. Physical Health. Self-care of Bodies.

Download Document

Here is the link to download the presentation.
"HIV and HCV Update for the Pharmacist – June 2014"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.